source
- FDA schedules first oncology advisory panel in nine months, will review AstraZeneca candidatesThe FDA announced it will hold an oncology advisory committee meeting roughly nine months from now. The meeting will focus on evaluating a pair of investigational drugs from AstraZeneca, though de…
- Bristol Myers Squibb faces identity crisis as CEO Chris Boerner enters make-or-break yearBristol Myers Squibb is at a strategic crossroads as its chief executive, Chris Boerner, approaches the midway point of his tenure. After roughly two and a half years in the role, Boerner has over…